Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Intangibles (2016 - 2025)

Cumberland Pharmaceuticals' Change in Intangibles history spans 16 years, with the latest figure at $43842.0 for Q4 2025.

  • For Q4 2025, Change in Intangibles rose 78.76% year-over-year to $43842.0; the TTM value through Dec 2025 reached $84402.0, down 25.47%, while the annual FY2025 figure was $84402.0, 25.47% down from the prior year.
  • Change in Intangibles for Q4 2025 was $43842.0 at Cumberland Pharmaceuticals, up from $8449.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $1.8 million in Q4 2022 and bottomed at $8449.0 in Q3 2025.
  • The 5-year median for Change in Intangibles is $35336.0 (2022), against an average of $146320.0.
  • The largest annual shift saw Change in Intangibles crashed 95.55% in 2021 before it surged 2451.73% in 2022.
  • A 5-year view of Change in Intangibles shows it stood at $70317.0 in 2021, then soared by 2451.73% to $1.8 million in 2022, then crashed by 96.26% to $67193.0 in 2023, then plummeted by 63.5% to $24526.0 in 2024, then soared by 78.76% to $43842.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Change in Intangibles are $43842.0 (Q4 2025), $8449.0 (Q3 2025), and $13912.0 (Q2 2025).